IJDDC

Loading...

IJDDC

IJDDC

International Journal Diabetes in Developing Countries

May - June, 2023 • Vol. 43 • # 3

Pattern of clinical/bacteriological profile and follow-up of symptomatic urinary tract infection in patients with diabetes: a cross-sectional study from North India

Diabetes patients have a higher risk of urinary tract infection (UTI). The present study was aimed at determining the clinical profile, microbial pattern, antibiotic sensitivity, and follow-up of UTI in patients with type 2 diabetes (T2D)

Follow-up frequency impacts metabolic control in diabetes patients under MMC framework - a retrospective study

Patients with type 2 diabetes mellitus (T2DM) have risk of cardiovascular complications if blood glucose, blood lipids, and blood pressure (BP) are not optimally controlled. National Metabolic Management Center (MMC) has established a new management model to improve metabolic control.

Telemedicine with advanced communication technology in management of type 2 diabetes mellitus: a network meta-analysis

Type 2 diabetes mellitus has risen to one of the most common chronic diseases worldwide, which puts heavy pressure on patients and the health-care system. Self-management is an important treatment for type 2 diabetes. New selfmanagement treatments have been making great progress with the development of the advanced telemedicine.

ORIGINAL ARTICLE Innovative mobile-health led participatory approach to comprehensive screening and treatment of diabetes (IMPACT diabetes): rationale, design, and baseline characteristics

India has 66 million people with diabetes, of which a large proportion do not receive adequate care. The primary health centres can serve as platforms for early detection of diabetes and continuum of care

Current insulinization trends in India

Hyperglycemia-associated micro- and macro-vascular complications remain the leading cause of premature morbidity and mortality among the diabetic population worldwide. Poor glycemic control due to clinical inertia towards insulin treatment is a major cause behind the development of diabetic complications. In this paper, we analyze different strategies of insulin treatment initialization and titration practiced in India.

Value of neutrophil/lymphocyte ratio in the diagnosis of diabetic neuropathy

Peripheral diabetic neuropathy (PDN) had been demonstrated as a chronic inflammation state and one of the most common complications of type 2 diabetes mellitus (T2DM). Neutrophil-to-lymphocyte ratio (NLR) is a novel marker to reflect many kinds of chronic inflammation disease including diabetes. We aim to evaluate the association between NLR and PDN and to determine whether NLR could be a new indicator of PDN in T2DM.

Serum glucose, a cost-effective alternate of plasma glucose in diagnosing and monitoring diabetes mellitus

Measurement of venous plasma glucose concentration (P-Glucose) requires preanalytical precautions: rapid cooling, rapid centrifugation, and using tubes with enzyme inhibitors. A special routine for measuring a biomarker that is critical and frequent in metabolic control is logistically demanding and expensive. We revisit and quantify the diagnostic outcome of using venous serum glucose concentration (S-Glucose) to diagnose diabetes mellitus (DM), using glycated hemoglobin (B-HbA1c) as the reference procedure for diagnosis.

National and regional prevalence rates of diabetes in Saudi Arabia: analysis of national survey data

The prevalence of diabetes mellitus (DM) has grown globally including Saudi Arabia. However, there are no recent national and regional reports about DM in Saudi Arabia. Therefore, this study aimed to explore the national and regional prevalence rates of DM among the Saudi population.

Follow-up frequency impacts metabolic control in diabetes patients under MMC framework - a retrospective study

Patients with type 2 diabetes mellitus (T2DM) have risk of cardiovascular complications if blood glucose, blood lipids, and blood pressure (BP) are not optimally controlled. National Metabolic Management Center (MMC) has established a new management model to improve metabolic control.

ORIGINAL ARTICLE Utilization of statins in patients with type 2 diabetes mellitus: the practice in a lower middle income South Asian country

Cardiovascular disease (CVD) is a major cause of morbidity and mortality among patients with type 2 diabetes. Statin reduces CVD risk. The ACC/AHA 2018 guideline on dyslipidemia recommends all patients with type 2 diabetes mellitus to be given moderate-intensity statin. We aimed to determine the prescription practices of statins among patients with type 2 diabetes mellitus.

Effect of stress hyperglycemia on admission and glycosylated hemoglobin on left ventricular function and inflammatory factors in patients with diabetes mellitus combined with myocardial infarction undergoing PCI

In this study, we analyzed the effect of stress hyperglycemia on patients admitted with diabetes mellitus. The effects of glycated hemoglobin (HbA1c) on left ventricular function and inflammatory factors in these patients with diabetes mellitus and myocardial infarction undergoing percutaneous coronary intervention (PCI) were also studied.

Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days

Lifestyle modification is an integral aspect for the management of type 2 diabetes (T2D). However, it is difficult to ensure the accuracy of personalized lifestyle advice. The study aims to analyse the real-world effectiveness of personalized glycemic response based Diabefly-Pro digital therapeutics for better glycemic control.

Insulin antibody as a biomarker to monitor the development of type 2 diabetes in county hospitals in China

The significance of insulin antibody (IA) detection in type 2 diabetes mellitus (T2DM) has received scant attention from county hospitals in China. We aimed to introduce exogenous IA positive rate and its relative factors in T2DM treated with insulin in Xiangshan County of Ningbo City, analyzing the immunogenicity of different kinds of insulin.

The youngest patient with hemi-chorea and diabetic ketoacidosis as presenting manifestation of type 1 diabetes mellitus from India

Type 1 diabetes mellitus (T1DM) is one of the most common endocrine diseases in children. Majority of them present with metabolic crises in the form of diabetic ketoacidosis (DKA) at diagnosis. Various levels of encephalopathy and seizures are the well-known manifestation of DKA.

Evaluation of progression in metabolic parameters along with markers of subclinical inflammation and atherosclerosis among normoglycemic first degree relatives of type 2 diabetes mellitus patients

The aim of this study is to assess for the change in progression of inflammatory, adiposity, and atherosclerotic markers in first degree relatives of type 2 diabetes mellitus patients.

Improvement of biochemical and hematological parameters in alloxan-induced diabetic rats via administration of ethanol extract of Garcinia kola seeds

Garcinia kola (Gluttiferae) is recommended traditionally for the management of diabetes in Nigeria. This present study evaluated the effect of the ethanol extract of G. kola seeds on the biochemical and hematological status of alloxan-induced diabetic rats.

Association of serum osteocalcin with beta cell function, insulin resistance, and glycemic parameters in south Indian type 2 diabetic subjects

Osteocalcin (OC), also known as bone Gla (gamma-carboxyglutamic acid) protein, is a marker of bone formation. OC has effect on glucose and fat metabolism. Role of OC in type 2 diabetes mellitus (T2DM) is not well studied in Indian population. Our study aimed to see the relationship between OC and parameters of glucose metabolism in type 2 diabetes mellitus.

Could the PON1 phenotype play a key role in insulin resistance?

Recent studies have shown that Paraoxonase (PON1) enzyme plays a possible role in insulin synthesis by stimulating insulin release from -cells of the pancreas as well as its anti-atherosclerotic property. In our study, we revealed the relationship between phenotypes of the PON1 enzyme and insulin resistance (IR) and impaired fasting glucose (IFG).